{"DataElement":{"publicId":"3148300","version":"1","preferredName":"Serum Aspartate Aminotransferase Measurement Hepatic Within Protocol Upper Limit of Normal Lab Ind-2","preferredDefinition":"the yes/no indicator related to the top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for quantitative measurement of the amount of aspartate aminotransferase present in a sample of serum.","longName":"3148299v1.0:2181518v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3148299","version":"1","preferredName":"Serum Aspartate Aminotransferase Measurement Hepatic Within Protocol Upper Limit of Normal Lab","preferredDefinition":"information related to the top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for quantitative measurement of the amount of aspartate aminotransferase present in a sample of serum.","longName":"3148297v1.0:2603675v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"3148302","version":"1","preferredName":"Serum Aspartate Aminotransferase Measurement Hepatic","preferredDefinition":"A quantitative measurement of the amount of aspartate aminotransferase present in a sample of serum.:Refers to the liver.","longName":"C61018:C13308","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Serum Aspartate Aminotransferase Measurement","conceptCode":"C61018","definition":"A quantitative measurement of the amount of aspartate aminotransferase present in a sample of serum.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hepatic","conceptCode":"C13308","definition":"Pertaining to, affecting, or associated with the liver.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"925C7390-6418-ABB1-E040-BB89AD432966","latestVersionIndicator":"Yes","beginDate":"2010-10-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-10-11","modifiedBy":"ONEDATA","dateModified":"2010-10-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2603675","version":"1","preferredName":"Within Protocol Upper Limit of Normal Laboratory","preferredDefinition":"On the inside; contained in.:An action plan for a clinical trial.  The plan states what the study will do, how, and why.  It explains how many people will be in it, who is eligible to participate, what study agents or other interventions they will be given, what tests they will receive and how often, and what information will be gathered.:The top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for particular laboratory result or other quantitative parameter.:Laboratory; a workplace for the conduct of scientific research.","longName":"C25282:C25320:C25706:C37984","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Within","conceptCode":"C25282","definition":"On the inside; contained in.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Clinical Study Protocol","conceptCode":"C25320","definition":"A formal document that describes a complete plan of research activity in the framework of a clinical study; specifically, the study objective(s), design, methodology, eligibility requests for prospective subjects and controls; intervention regimen(s), proposed methods of analysis of data; statistical considerations, and organization of the study. The protocol usually also provides the background and rationale for the study, but these could be represented in other protocol referenced documents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Upper Limit of Normal","conceptCode":"C25706","definition":"The top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for particular laboratory result or other quantitative parameter.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Laboratory","conceptCode":"C37984","definition":"A facility equipped and competent to conduct scientific experiments, observations, tests, investigations, and/or to manufacture chemicals or medical products.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2A7B033B-7BCC-32EF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-27","modifiedBy":"ONEDATA","dateModified":"2007-02-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCCTG CRF:North Central Cancer Treatment Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"925C7390-63D4-ABB1-E040-BB89AD432966","latestVersionIndicator":"Yes","beginDate":"2010-10-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-10-11","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104889","version":"1","longName":"GOG-0229K","context":"NRG"}]}],"AlternateNames":[{"name":"3148299v1.0:2181518v1.0","type":"USED_BY","context":"NRG"},{"name":"3148299v1.0:2181518v1.0","type":"USED_BY","context":"CITN"},{"name":"3148299v1.0:2181518v1.0","type":"USED_BY","context":"TEST"},{"name":"Alliance","type":"USED_BY","context":"Alliance"}],"ReferenceDocuments":[{"name":"Aspartate transaminase (AST)","type":"Preferred Question Text","description":"Aspartate transaminase (AST) <=2.5 x ULN","url":null,"context":"CTEP"},{"name":"CRF Text3","type":"Alternate Question Text","description":"SGOT (AST) <=2.5 x ULN","url":null,"context":"CTEP"},{"name":"CRF Text2","type":"Alternate Question Text","description":"SGOT (AST) <=3 x ULN, unless evidence of direct liver involvement by lymphoma, then <=5 x ULN","url":null,"context":"CTEP"},{"name":"CRF Text5","type":"Alternate Question Text","description":"Is the AST less than or equal to 3 X ULN?","url":null,"context":"CTEP"},{"name":"CRF Text4","type":"Alternate Question Text","description":"SGOT (AST) <=3 x ULN","url":null,"context":"CTEP"},{"name":"CRF Text6","type":"Alternate Question Text","description":"AST (SGOT) <=2 x institutional upper limit of normal (ULN)","url":null,"context":"CTEP"},{"name":"CRF Text7","type":"Alternate Question Text","description":"AST (SGOT) <=2.5 x institutional upper limit of normal (ULN)","url":null,"context":"CTEP"},{"name":"CRF Text 8","type":"Alternate Question Text","description":"AST (SGOT) within institutional normal limits","url":null,"context":"CTEP"},{"name":"CRF Text 9","type":"Alternate Question Text","description":"AST (SGOT) within institutional limits","url":null,"context":"CTEP"},{"name":"CRF Text 11","type":"Alternate Question Text","description":"AST (SGOT) <= 2.5 x institutional ULN","url":null,"context":"CTEP"},{"name":"CRF Text 10","type":"Alternate Question Text","description":"AST (SGOT) <=2.5 x institutional upper limit of normal","url":null,"context":"CTEP"},{"name":"CITN","type":"Alternate Question Text","description":"AST (SGOT) < 2.5 x institutional ULN (Values post biliary stenting are allowed for eligibility).","url":null,"context":"CITN"},{"name":"CRF Text12","type":"Alternate Question Text","description":"SGOT (AST) less than or equal to 3.0 x upper limit of normal (ULN)?","url":null,"context":"Alliance"}],"origin":"NCCTG CRF:North Central Cancer Treatment Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"925C7390-63E6-ABB1-E040-BB89AD432966","latestVersionIndicator":"Yes","beginDate":"2010-10-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-10-11","modifiedBy":"MORENOC","dateModified":"2021-08-09","changeDescription":"Replaced VD Labs Ind-2  2181518v1.0 with VD ID#3506068 - Yes No Indicator - dbw","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}